Results 221 to 230 of about 10,935,890 (352)

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

National and subnational trends of years of life lost and reduced life expectancy caused by bladder cancer in China from 2005 to 2020. [PDF]

BMC Public Health
Liu Z, Yu L, Yan F, Qi J, Wang L, Zhou M, Yin P.   +6 more
europepmc   +1 more source

THE PRESENT STATUS OF TEE CANCER PROBLEM

, 1931
Clarence C. Little, BAR HARBOR
openalex   +2 more sources

On the Relation of Diets to the Development, Prevention and Treatment of Cancer, with Special Reference to Cancer of the Stomach and Liver [PDF]

, 1951
Kanematsu Sugiura
openalex   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Gastric cancer

, 2021
openaire   +1 more source

Self efficacy as a key mediator for cervical cancer screening behavior. [PDF]

Sci Rep
Ghasemi M, Savabi-Esfahani M, Noroozi M, Satari M.   +3 more
europepmc   +1 more source

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

Molecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin, Kjersti Tjensvoll, Karin Hestnes Edland, Satu Oltedal, Herish Garresori, Bjørnar Gilje, Saga Ekedal, Trygve Eftestøl, Jan Terje Kvaløy, Filip Janku, Oddmund Nordgård   +10 more
wiley   +1 more source

Increased cancer risk in patients with IgG4-related disease in a nationwide South Korean cohort, 2012-2021. [PDF]

Sci Rep
So H, Choi SJ, Park S, Park M, Lim DH.
europepmc   +1 more source

The Family-History of Cancer-Patients [PDF]

, 1884
W. R. Williams
openalex   +1 more source